This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Dainippon Ink and Chemicals, Incorporated, Activus Pharma Co., Ltd., Mariposa Health Limited. Active years: 1985-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ichihara, JP (1985)
- Chiba, JP (1996)
- Sakura, JP (1989 - 2015)
Company Filing History:
16 out of 630 
1 out of 7 
1 out of 1 Years Active: 1985-2015
Areas of Expertise:
Title: Innovations of Hidetsugu Takagaki
Introduction
Hidetsugu Takagaki is a prominent inventor based in Sakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for various diseases. With a total of 18 patents to his name, Takagaki's work has had a substantial impact on medical treatments.
Latest Patents
Among his latest patents, Takagaki has developed a therapeutic agent for chronic obstructive pulmonary disease (COPD) and a method for treating this condition. This innovative therapeutic agent comprises an active ingredient, specifically a 7-aminoquinolinone derivative represented by a general formula. Additionally, he has created a quaternary ammonium compound that serves as a therapeutic agent for cerebrovascular disorders and heart diseases. The compound is characterized by a complex structure that includes various alkyl groups and functional groups, showcasing his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Takagaki has worked with notable companies such as Dainippon Ink and Chemicals, Incorporated and Mariposa Health Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Takagaki has collaborated with esteemed colleagues, including Nobuyuki Kimura and Masayoshi Abe. These partnerships have fostered an environment of innovation and have led to the successful development of various therapeutic agents.
Conclusion
Hidetsugu Takagaki's contributions to the field of pharmaceuticals are noteworthy, with a focus on developing effective treatments for chronic diseases. His innovative spirit and collaborative efforts continue to drive advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile